Selected Publications
Brian G Feagan, Bruce E Sands, William J Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao, Shihong Sheng, Jewel Johanns, Julián Panés: Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial Lancet Gastroenterol Hepatol 8 (4): 307-320,2023.
Sandborn WJ, D'Haens GR, Reinisch W, Panés J, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG; GALAXI-1 Investigators.: Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology 162 (6): 1650-1664.e8.,2022.
Dreskin SC, Germinaro M, Reinhold D, Chen X, Vickery BP, Kulis M, Burks AW, Negi SS, Braun W, Chambliss J, Eglite S, McNulty CMG.: IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy. Pediatr Allergy Immunol
30 (8): 817-823,2019.
Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M.: Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract 7 (2): 589-596.e3,2019.
Bateman ED, Djukanovic R, Castro M, Canvin J, Germinaro M, Noble R, Garin M, Buhl R.: Predicting Responders to Reslizumab After 16 Weeks of Treatment Using an Algorithm Derived From Clinical Studies of Patients with Severe Eosinophilic Asthma. Am J Respir Crit Care Med 199 (4): 489-495,2019.
Brusselle G, Germinaro M, Weiss S, Zangrilli J.: Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils. Pulm Pharmacol Ther 43 : 39-45,2017.
Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M.: Reslizumab for Inadequately Controlled Asthma with Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. CHEST 150 (4): 789-798,2016.
Germinaro, M., Reynolds, P., Knight, V., Alam, R.: Association of B-cell activating factor receptor deficiency with the P21R polymorphism and common variable immunodeficiency. Ann Allergy Asthma Immunol 115 (1): 82-83,2015.
Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, Malhotra V, Sood N, Midda V, Monga DK, Kokkinakis DM, Monga SP: Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8 (4): 279-289,2006.
Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A.: beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation. Cell and Tissue Research 323 (1): 71-79,2006.
Academic Contact Information
Allergy and Immunology
Penn Medicine University City
3737 Market Street, 3rd floor
Philadelphia,
PA
19104
Phone: 800-789-7366
Patient appointments: 800-789-7366